REGENXBIO, Inc. (RGNX)
6.34
+0.21
(+3.43%)
USD |
NASDAQ |
Jun 09, 16:00
6.34
0.00 (0.00%)
After-Hours: 20:00
REGENXBIO SG&A Expense (Quarterly) : 21.31M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Ocugen, Inc. | 8.117M |
| Capricor Therapeutics, Inc. | 9.396M |
| Krystal Biotech, Inc. | 41.01M |
| Biogen, Inc. | 607.30M |
| AbbVie, Inc. | 3.578B |